Annual EBIT
$7.80 B
+$1.05 B+15.62%
31 December 2023
Summary:
Gilead Sciences annual earnings before interest & taxes is currently $7.80 billion, with the most recent change of +$1.05 billion (+15.62%) on 31 December 2023. During the last 3 years, it has risen by +$5.15 billion (+194.12%). GILD annual EBIT is now -65.08% below its all-time high of $23.45 billion.GILD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$1.19 B
-$1.10 B-47.86%
30 September 2024
Summary:
Gilead Sciences quarterly earnings before interest & taxes is currently $1.19 billion, with the most recent change of -$1.10 billion (-47.86%) on 30 September 2024. Over the past year, it has dropped by -$1.36 billion (-53.18%). GILD quarterly EBIT is now -78.93% below its all-time high of $5.67 billion, reached on 31 December 2015.GILD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$1.16 B
-$1.36 B-53.96%
30 September 2024
Summary:
Gilead Sciences TTM earnings before interest & taxes is currently $1.16 billion, with the most recent change of -$1.36 billion (-53.96%) on 30 September 2024. Over the past year, it has dropped by -$7.00 billion (-85.81%). GILD TTM EBIT is now -94.82% below its all-time high of $22.35 billion, reached on 31 December 2015.GILD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.6% | -53.2% | -85.8% |
| 3 y3 years | +194.1% | -67.6% | -88.8% |
| 5 y5 years | -12.1% | +195.4% | -78.1% |
GILD EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -15.9% | +194.1% | -67.6% | +128.2% | -88.8% | at low |
| 5 y | 5 years | -15.9% | +194.1% | -67.6% | +128.2% | -88.8% | +186.4% |
| alltime | all time | -65.1% | +6565.4% | -78.9% | +128.2% | -94.8% | +1058.7% |
Gilead Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.19 B(-47.9%) | $1.16 B(-54.0%) |
| June 2024 | - | $2.29 B(-154.1%) | $2.51 B(+23.1%) |
| Mar 2024 | - | -$4.23 B(-322.2%) | $2.04 B(-73.8%) |
| Dec 2023 | $7.80 B(+15.6%) | $1.91 B(-25.3%) | $7.80 B(-4.3%) |
| Sept 2023 | - | $2.55 B(+40.3%) | $8.15 B(-1.3%) |
| June 2023 | - | $1.82 B(+18.8%) | $8.27 B(+0.9%) |
| Mar 2023 | - | $1.53 B(-32.2%) | $8.19 B(+21.4%) |
| Dec 2022 | $6.75 B(-27.3%) | $2.26 B(-15.2%) | $6.75 B(+23.0%) |
| Sept 2022 | - | $2.66 B(+52.5%) | $5.49 B(-15.8%) |
| June 2022 | - | $1.75 B(+1929.1%) | $6.52 B(-4.8%) |
| Mar 2022 | - | $86.00 M(-91.4%) | $6.84 B(-26.2%) |
| Dec 2021 | $9.28 B(+249.8%) | $997.00 M(-73.0%) | $9.28 B(-10.5%) |
| Sept 2021 | - | $3.69 B(+77.9%) | $10.36 B(+34.0%) |
| June 2021 | - | $2.07 B(-17.8%) | $7.74 B(+164.0%) |
| Mar 2021 | - | $2.52 B(+21.1%) | $2.93 B(+10.4%) |
| Dec 2020 | $2.65 B(-56.9%) | $2.08 B(+96.1%) | $2.65 B(-2.3%) |
| Sept 2020 | - | $1.06 B(-138.8%) | $2.72 B(+572.3%) |
| June 2020 | - | -$2.73 B(-221.8%) | $404.00 M(-93.0%) |
| Mar 2020 | - | $2.24 B(+4.7%) | $5.79 B(-5.8%) |
| Dec 2019 | $6.16 B(-30.7%) | $2.14 B(-271.4%) | $6.16 B(+16.5%) |
| Sept 2019 | - | -$1.25 B(-147.1%) | $5.28 B(-44.2%) |
| June 2019 | - | $2.66 B(+2.1%) | $9.46 B(+3.3%) |
| Mar 2019 | - | $2.60 B(+104.6%) | $9.16 B(+3.2%) |
| Dec 2018 | $8.88 B(-39.4%) | $1.27 B(-56.5%) | $8.88 B(-11.5%) |
| Sept 2018 | - | $2.93 B(+24.5%) | $10.03 B(-9.3%) |
| June 2018 | - | $2.35 B(+1.2%) | $11.06 B(-15.5%) |
| Mar 2018 | - | $2.32 B(-4.1%) | $13.09 B(-10.6%) |
| Dec 2017 | $14.65 B(-18.9%) | $2.42 B(-38.8%) | $14.65 B(-10.7%) |
| Sept 2017 | - | $3.96 B(-9.6%) | $16.41 B(-3.3%) |
| June 2017 | - | $4.38 B(+13.0%) | $16.96 B(-1.4%) |
| Mar 2017 | - | $3.88 B(-7.3%) | $17.21 B(-4.7%) |
| Dec 2016 | $18.06 B(-19.2%) | $4.18 B(-7.4%) | $18.06 B(-7.6%) |
| Sept 2016 | - | $4.52 B(-2.3%) | $19.54 B(-5.4%) |
| June 2016 | - | $4.63 B(-2.2%) | $20.66 B(-4.7%) |
| Mar 2016 | - | $4.73 B(-16.5%) | $21.69 B(-3.0%) |
| Dec 2015 | $22.35 B(+46.4%) | $5.67 B(+0.5%) | $22.35 B(+6.2%) |
| Sept 2015 | - | $5.64 B(-0.2%) | $21.04 B(+11.5%) |
| June 2015 | - | $5.65 B(+4.8%) | $18.88 B(+7.0%) |
| Mar 2015 | - | $5.39 B(+23.7%) | $17.64 B(+15.5%) |
| Dec 2014 | $15.27 B(+238.2%) | $4.36 B(+25.5%) | $15.27 B(+26.2%) |
| Sept 2014 | - | $3.48 B(-21.2%) | $12.09 B(+23.8%) |
| June 2014 | - | $4.41 B(+45.7%) | $9.77 B(+49.9%) |
| Mar 2014 | - | $3.02 B(+155.1%) | $6.52 B(+44.4%) |
| Dec 2013 | $4.51 B(+13.6%) | $1.19 B(+2.8%) | $4.51 B(+1.7%) |
| Sept 2013 | - | $1.15 B(+0.0%) | $4.44 B(+2.6%) |
| June 2013 | - | $1.15 B(+12.9%) | $4.32 B(+2.3%) |
| Mar 2013 | - | $1.02 B(-7.8%) | $4.23 B(+6.4%) |
| Dec 2012 | $3.97 B(+3.0%) | $1.11 B(+6.5%) | $3.97 B(+5.7%) |
| Sept 2012 | - | $1.04 B(-1.7%) | $3.76 B(+0.6%) |
| June 2012 | - | $1.06 B(+38.1%) | $3.74 B(+0.8%) |
| Mar 2012 | - | $766.10 M(-14.3%) | $3.71 B(-3.9%) |
| Dec 2011 | $3.86 B(-4.1%) | $893.84 M(-12.2%) | $3.86 B(+1.4%) |
| Sept 2011 | - | $1.02 B(-1.0%) | $3.80 B(+0.6%) |
| June 2011 | - | $1.03 B(+12.3%) | $3.78 B(+0.5%) |
| Mar 2011 | - | $915.80 M(+9.0%) | $3.76 B(-6.5%) |
| Dec 2010 | $4.02 B(+12.6%) | $840.14 M(-15.5%) | $4.02 B(-5.6%) |
| Sept 2010 | - | $994.67 M(-1.6%) | $4.26 B(+2.1%) |
| June 2010 | - | $1.01 B(-14.1%) | $4.17 B(+6.0%) |
| Mar 2010 | - | $1.18 B(+9.3%) | $3.94 B(+10.2%) |
| Dec 2009 | $3.57 B(+30.4%) | $1.08 B(+18.5%) | $3.57 B(+9.7%) |
| Sept 2009 | - | $908.42 M(+17.4%) | $3.25 B(+7.1%) |
| June 2009 | - | $773.98 M(-4.7%) | $3.04 B(+5.4%) |
| Mar 2009 | - | $812.47 M(+6.9%) | $2.89 B(+4.4%) |
| Dec 2008 | $2.74 B(+26.5%) | $759.70 M(+9.5%) | $2.76 B(+9.7%) |
| Sept 2008 | - | $693.83 M(+12.0%) | $2.52 B(+6.2%) |
| June 2008 | - | $619.54 M(-10.3%) | $2.37 B(+3.3%) |
| Mar 2008 | - | $690.75 M(+34.3%) | $2.30 B(+6.0%) |
| Dec 2007 | $2.16 B | $514.49 M(-5.9%) | $2.16 B(+1.4%) |
| Sept 2007 | - | $547.03 M(+0.8%) | $2.14 B(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $542.85 M(-3.1%) | $2.00 B(+9.7%) |
| Mar 2007 | - | $560.14 M(+15.4%) | $1.82 B(+11.5%) |
| Dec 2006 | $1.64 B(+47.4%) | $485.22 M(+17.5%) | $1.64 B(+8.3%) |
| Sept 2006 | - | $413.11 M(+13.1%) | $1.51 B(+12.3%) |
| June 2006 | - | $365.31 M(-1.7%) | $1.35 B(+7.0%) |
| Mar 2006 | - | $371.65 M(+3.3%) | $1.26 B(+13.4%) |
| Dec 2005 | $1.11 B(+76.8%) | $359.84 M(+45.0%) | $1.11 B(+21.8%) |
| Sept 2005 | - | $248.25 M(-10.5%) | $910.22 M(+10.2%) |
| June 2005 | - | $277.50 M(+24.2%) | $825.74 M(+16.9%) |
| Mar 2005 | - | $223.48 M(+38.8%) | $706.44 M(+12.6%) |
| Dec 2004 | $627.39 M(+90.2%) | $161.00 M(-1.7%) | $627.39 M(+13.2%) |
| Sept 2004 | - | $163.77 M(+3.5%) | $554.37 M(+18.0%) |
| June 2004 | - | $158.20 M(+9.5%) | $469.77 M(+12.0%) |
| Mar 2004 | - | $144.42 M(+64.2%) | $419.35 M(+27.1%) |
| Dec 2003 | $329.92 M(+307.3%) | $87.98 M(+11.1%) | $329.92 M(+20.1%) |
| Sept 2003 | - | $79.17 M(-26.5%) | $274.79 M(+18.7%) |
| June 2003 | - | $107.77 M(+95.9%) | $231.53 M(+62.0%) |
| Mar 2003 | - | $55.00 M(+67.5%) | $142.95 M(+76.5%) |
| Dec 2002 | $81.01 M(-167.1%) | $32.84 M(-8.6%) | $81.01 M(+248.5%) |
| Sept 2002 | - | $35.92 M(+87.1%) | $23.24 M(-147.7%) |
| June 2002 | - | $19.19 M(-376.5%) | -$48.74 M(-52.1%) |
| Mar 2002 | - | -$6.94 M(-72.1%) | -$101.83 M(-15.6%) |
| Dec 2001 | -$120.69 M(+130.7%) | -$24.92 M(-30.9%) | -$120.69 M(+5.5%) |
| Sept 2001 | - | -$36.07 M(+6.4%) | -$114.42 M(+15.2%) |
| June 2001 | - | -$33.90 M(+31.4%) | -$99.29 M(+39.8%) |
| Mar 2001 | - | -$25.80 M(+38.3%) | -$71.03 M(+43.0%) |
| Dec 2000 | -$52.32 M(+1.2%) | -$18.65 M(-10.9%) | -$49.68 M(+119.5%) |
| Sept 2000 | - | -$20.94 M(+271.6%) | -$22.63 M(-31.2%) |
| June 2000 | - | -$5.63 M(+26.6%) | -$32.89 M(-17.0%) |
| Mar 2000 | - | -$4.45 M(-153.0%) | -$39.62 M(-23.4%) |
| Dec 1999 | -$51.70 M(-34.0%) | $8.40 M(-126.9%) | -$51.72 M(-36.2%) |
| Sept 1999 | - | -$31.20 M(+152.4%) | -$81.02 M(+13.4%) |
| June 1999 | - | -$12.36 M(-25.3%) | -$71.42 M(-9.4%) |
| Mar 1999 | - | -$16.55 M(-20.8%) | -$78.85 M(+5.8%) |
| Dec 1998 | -$78.30 M(+8.6%) | -$20.90 M(-3.2%) | -$74.50 M(-23.4%) |
| Sept 1998 | - | -$21.60 M(+9.1%) | -$97.20 M(+7.2%) |
| June 1998 | - | -$19.80 M(+62.3%) | -$90.70 M(+25.4%) |
| Mar 1998 | - | -$12.20 M(-72.0%) | -$72.30 M(+0.4%) |
| Dec 1997 | -$72.10 M(+99.7%) | -$43.60 M(+188.7%) | -$72.00 M(+76.9%) |
| Sept 1997 | - | -$15.10 M(+978.6%) | -$40.70 M(+102.5%) |
| June 1997 | - | -$1.40 M(-88.2%) | -$20.10 M(-41.9%) |
| Mar 1997 | - | -$11.90 M(-3.3%) | -$34.60 M(-3.9%) |
| Dec 1996 | -$36.10 M(+12.8%) | -$12.30 M(-323.6%) | -$36.00 M(+51.9%) |
| Sept 1996 | - | $5.50 M(-134.6%) | -$23.70 M(-39.4%) |
| June 1996 | - | -$15.90 M(+19.5%) | -$39.10 M(+21.4%) |
| Mar 1996 | - | -$13.30 M(+34.3%) | -$32.20 M(-15.5%) |
| Dec 1995 | -$32.00 M(-9.1%) | - | - |
| Sept 1995 | - | -$9.90 M(+10.0%) | -$38.10 M(+5.5%) |
| June 1995 | - | -$9.00 M(-10.0%) | -$36.10 M(+2.6%) |
| Mar 1995 | - | -$10.00 M(+8.7%) | -$35.20 M(+2.6%) |
| Mar 1995 | -$35.20 M(+19.3%) | - | - |
| Dec 1994 | - | -$9.20 M(+16.5%) | -$34.30 M(+4.9%) |
| Sept 1994 | - | -$7.90 M(-2.5%) | -$32.70 M(+3.5%) |
| June 1994 | - | -$8.10 M(-11.0%) | -$31.60 M(+7.8%) |
| Mar 1994 | -$29.50 M(+62.1%) | -$9.10 M(+19.7%) | -$29.30 M(+8.1%) |
| Dec 1993 | - | -$7.60 M(+11.8%) | -$27.10 M(+11.5%) |
| Sept 1993 | - | -$6.80 M(+17.2%) | -$24.30 M(+14.6%) |
| June 1993 | - | -$5.80 M(-15.9%) | -$21.20 M(+16.5%) |
| Mar 1993 | -$18.20 M(+188.9%) | -$6.90 M(+43.8%) | -$18.20 M(-1.6%) |
| Dec 1992 | - | -$4.80 M(+29.7%) | -$18.50 M(+40.2%) |
| Sept 1992 | - | -$3.70 M(+32.1%) | -$13.20 M(+41.9%) |
| June 1992 | - | -$2.80 M(-61.1%) | -$9.30 M(+47.6%) |
| Mar 1992 | -$6.30 M(+31.3%) | -$7.20 M(-1540.0%) | -$6.30 M(+57.5%) |
| Dec 1991 | - | $500.00 K(+150.0%) | -$4.00 M(-9.1%) |
| Sept 1991 | - | $200.00 K(0.0%) | -$4.40 M(-2.2%) |
| June 1991 | - | $200.00 K(-104.1%) | -$4.50 M(-2.2%) |
| Mar 1991 | -$4.80 M | -$4.90 M(-5000.0%) | -$4.60 M(-1633.3%) |
| Dec 1990 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Sept 1990 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1990 | - | $100.00 K | $100.00 K |
FAQ
- What is Gilead Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Gilead Sciences?
- What is Gilead Sciences annual EBIT year-on-year change?
- What is Gilead Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Gilead Sciences?
- What is Gilead Sciences quarterly EBIT year-on-year change?
- What is Gilead Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Gilead Sciences?
- What is Gilead Sciences TTM EBIT year-on-year change?
What is Gilead Sciences annual earnings before interest & taxes?
The current annual EBIT of GILD is $7.80 B
What is the all time high annual EBIT for Gilead Sciences?
Gilead Sciences all-time high annual earnings before interest & taxes is $23.45 B
What is Gilead Sciences annual EBIT year-on-year change?
Over the past year, GILD annual earnings before interest & taxes has changed by +$1.05 B (+15.62%)
What is Gilead Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of GILD is $1.19 B
What is the all time high quarterly EBIT for Gilead Sciences?
Gilead Sciences all-time high quarterly earnings before interest & taxes is $5.67 B
What is Gilead Sciences quarterly EBIT year-on-year change?
Over the past year, GILD quarterly earnings before interest & taxes has changed by -$1.36 B (-53.18%)
What is Gilead Sciences TTM earnings before interest & taxes?
The current TTM EBIT of GILD is $1.16 B
What is the all time high TTM EBIT for Gilead Sciences?
Gilead Sciences all-time high TTM earnings before interest & taxes is $22.35 B
What is Gilead Sciences TTM EBIT year-on-year change?
Over the past year, GILD TTM earnings before interest & taxes has changed by -$7.00 B (-85.81%)